表紙
市場調查報告書

遺傳基因檢驗的全球市場

Genetic Testing

出版商 Global Industry Analysts, Inc. 商品編碼 236763
出版日期 內容資訊 英文 79 Pages
商品交期: 最快1-2個工作天內
價格
遺傳基因檢驗的全球市場 Genetic Testing
出版日期: 2020年02月01日內容資訊: 英文 79 Pages
簡介

本報告以遺傳基因檢驗的全球市場為焦點,依產品市場區隔 (產前及新生兒遺傳基因檢驗藥理基因學檢驗,預測診斷) 及地區 (美國,加拿大,日本,歐洲,亞太地區,其他) 別檢驗·預測2014-2020年這段期間之交易金額,並彙整過去7年的市場過程分析和大小86家參與企業公司的簡介等目前競爭環境相關的調查資訊。

第1章 簡介,調查方法,產品定義

  • 調查的可靠性和報告的限制
  • 免責聲明
  • 資料的解釋和報告作成層級
    • 定量技術與分析
  • 產品的定義和調查範圍
    • 產前及新生兒遺傳基因檢驗藥理遺傳基因檢驗,藥理基因學檢驗
    • 預測診斷

第2章 摘要整理

  • 全球市場概要
    • 概要基礎知識
    • 全球10大遺傳基因障礙
    • 遺傳基因檢驗-宣告新時代的到來
    • 穩固定制醫療地位的遺傳基因檢驗
    • 全球人口膨脹帶來的成長機會擴大
    • 因人口高齡化而加速的遺傳基因檢驗市場
    • 因醫療支出的提高促使需求大幅增加
    • 遺傳基因檢驗-正在急速發展對體外診斷(IVD)市場而言不可或缺的因素
    • 遺傳基因檢驗-分子診斷市場的急速成長市場區隔
    • 遺傳檢驗的進步相關之生物標記的發現
    • 美國食品藥物管理局核準的癌症生物標記一覽
  • 市場區隔考察
    • 興起的產前檢查
    • 各現象,表現症狀,盛行率別之遺傳基因障礙一覽
    • 產前檢查-改變妊娠治療世界之物
    • 產前檢查-基本的概要
    • 可利用的產前篩檢及診斷法的症狀別一覽
    • 傳統的產前診斷技術-伴隨危險性的工作
    • 激化的胎兒染色體檢驗(NIPD)市場上的競爭
    • 排除傳統診斷法的危險性和不確定性之胎兒染色體檢驗
    • 對胎兒染色體檢驗法的異議-普及的一大難關
    • 產前檢查的優點和阻礙普及的倫理問題
    • 優點超越潛在性障礙的胎兒染色體檢驗
    • 影響胎兒染色體檢驗普及的主要係數
    • 胎兒染色體檢驗可望用途的多樣性
    • 預測診斷
    • 穩定擴大的乳癌遺傳基因檢驗市場
    • 多元化的遺傳學-乳癌檢驗中不容置疑的第一領域
    • 例行性臨床試驗 vs.預測遺傳基因檢驗
    • CDD發生數·盛行率的擴大-主要成長推動要素
    • 預測診斷不可或缺的新型生物標記的發現
    • 未解決的問題 一以遺傳基因疾病為對象的遺傳基因診斷和檢驗廣泛實施之妨礙
    • 遺傳基因諮詢師的不足-對預測遺傳基因測試市場而言的一大障礙
    • 藥理基因學的發展為遺傳基因檢驗市場成長帶來吉兆
  • 市場趨勢
    • 門診病人(Direct-to-Consumer)遺傳基因檢驗-遺傳基因檢驗市場上主要趨勢
    • 製作新企業的平台
    • 門診病人遺傳基因檢驗經營者的經營模式
    • 擴大門診病人遺傳基因檢驗的知名度- 優劣點
    • 胚胎著床前遺傳基因診斷(PGD)-遺傳基因檢驗市場主要推動材料
    • 全基因譯解-在遺傳基因檢驗的功與過
    • 興起的老年癡呆症患者遺傳基因檢驗的有效性
    • wafarin研究目的遺傳基因檢驗的效用
    • 腫瘤學-遺傳基因檢驗基礎重點領域
    • 遺傳基因檢驗同時也具有助於中樞神經系統疾病治療的可能性
    • 神經退化性疾病-遺傳基因檢驗市場代表性重點領域
    • 老年癡呆症
    • 亨丁頓舞蹈症
    • 遺傳基因檢驗-囊狀纖維化症不可或缺的工具
    • 組織適合性檢驗
    • 次世代定序 - 基因譯解巨大的一步
    • 兒童遺傳基因檢驗讓成人期發病疾病篩檢急速獲得支持
    • 需要改善的全球遺傳基因檢驗產業之安全性規定
    • 面臨的課題
    • 遺傳諮詢 -提升的機會
    • 透過線上的措施
    • 因ACOG (The American congress of obstetricians and gynecologists) 及 ACGM (Advisory Committee on Genetic Modification) 推薦而擴大的囊狀纖維化症檢驗的需求
    • 倫理問題和恰當的法規政策之必要性
    • 肥胖的遺傳基因檢驗相關問題點
    • 妊娠期的診斷和治療-減少梅毒相關的死亡·死產的有效的方法
  • 分子診斷市場 - 考察
    • 急速成長轉向的全球分子診斷
    • 因自動化加速的全球市場
    • 分子診斷-多方面的技術融合所形成
    • 急速發展的傳染病分子診斷市場
    • 人口高齡化,疾病發生-成長基礎的推動要素
    • 視分子診斷市場為自家公司專門領域之醫藥品廠商
    • 訂製針對適當疾病的適當治療
    • 透過第三方機關的有限醫療報酬-障礙
    • 促使臨床結果提升的疾病特定型分子診斷
    • 分子診斷和智慧財產權
    • 不久的將來的商機
    • 醫療訓練及診療行為的課題
    • 對著眼於分子診斷的企業整體而言的障礙
    • 產品行銷 -商業性成功關鍵
    • 合併分子診斷的治療
    • 分子診斷-從集中化轉換到分權化
    • 分子診斷市場競爭環境
    • 其他值得注意的企業和各公司的不同市場區隔競爭地位
    • 著眼於未滿足需求的新加入企業
  • 產品概要
    • 遺傳基因檢驗相關的開場白
    • 遺傳基因檢驗及其使用目的
    • 候補遺傳基因與基因區分
    • 遺傳基因的DNA晶片
    • 遺傳基因變異的檢測所採用的技術
    • 遺傳基因檢驗的種類
    • 產前診斷
    • 癌症篩檢
    • 保原因者檢測
    • 新生兒診察
    • 預測實驗
    • 發病前檢驗
    • 細胞遺傳學檢驗
    • 遺傳基因檢驗流程的階段
    • 規定
    • 風險之外細胞遺傳學檢驗的規定
    • 遺傳基因檢驗的得到好處的醫療機關
    • 藥物遺傳學,藥理基因學
    • 代表性遺傳基因檢驗檢討
    • 囊狀纖維化症
    • 乳癌及卵巢癌症 (BRCA)
    • 老年癡呆症
    • 大腸癌症
    • 血鐵沉著症 (HH)
    • Cowden氏病
    • 亨丁頓舞蹈症
    • 有代表性的檢驗的費用
    • 遺傳基因檢驗的技術
    • 信號放大技術
    • 定量即時PCR分析
    • 非PCR法
    • 其他信號放大技術
    • DNA探針利用產品
  • 產品銷售·技術創新
  • 最新產業趨勢
  • 全球主要加入企業
  • 全球市場預測

第3章 市場

  • 美國
  • 加拿大
  • 日本
  • 歐洲
    • 法國
    • 德國
    • 義大利
    • 英國
    • 其他歐洲各國
  • 亞太地區
  • 其他地區

第4章 競爭環境

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: MCP-1392

Genetic Testing market worldwide is projected to grow by US$7.6 Billion, driven by a compounded growth of 14%. Genetic Testing, one of the segments analyzed and sized in this study, displays the potential to grow at over 14%. The shifting dynamics supporting this growth makes it critical for businesses in this space to keep abreast of the changing pulse of the market. Poised to reach over US$12.6 Billion by the year 2025, Genetic Testing will bring in healthy gains adding significant momentum to global growth.

Representing the developed world, the United States will maintain a 15% growth momentum. Within Europe, which continues to remain an important element in the world economy, Germany will add over US$299.8 Million to the region's size and clout in the next 5 to 6 years. Over US$363.1 Million worth of projected demand in the region will come from Rest of Europe markets. In Japan, Genetic Testing will reach a market size of US$852.9 Million by the close of the analysis period. As the world's second largest economy and the new game changer in global markets, China exhibits the potential to grow at 13.8% over the next couple of years and add approximately US$1.3 Billion in terms of addressable opportunity for the picking by aspiring businesses and their astute leaders. Presented in visually rich graphics are these and many more need-to-know quantitative data important in ensuring quality of strategy decisions, be it entry into new markets or allocation of resources within a portfolio. Several macroeconomic factors and internal market forces will shape growth and development of demand patterns in emerging countries in Asia-Pacific. All research viewpoints presented are based on validated engagements from influencers in the market, whose opinions supersede all other research methodologies.

Competitors identified in this market include, among others,

  • 23andMe Inc.
  • Abbott Laboratories
  • AutoGenomics Inc.
  • Biocartis NV
  • BioRad Laboratories
  • Cepheid Inc.
  • ELITech Group S.P.A.
  • Illumina Inc.
  • Laboratory Corporation of America Holdings
  • Sequenom Inc.
  • Luminex Corporation
  • Natera Inc.
  • PerkinElmer Inc.
  • QIAGEN N.V.
  • Quest Diagnostics Inc.
  • Roche Diagnostics AG.
  • Roche Molecular Diagnostics Inc.
  • Thermo Fisher Scientific

TABLE OF CONTENTS

I. INTRODUCTION, METHODOLOGY & REPORT SCOPE

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW

  • Recent Market Activity
  • A Prelude
  • Top Ten Genetic Disorders Worldwide
  • Genetic Testing Market Experiences Exponential Growth
  • Regional Landscape
  • Key Challenges
  • Genetic Testing Paves the Way for Personalized Medicine
  • Next-Generation Sequencing (NGS) - A Giant Leap in Genome Sequencing
  • Biomarker Discovery Leads to Advanced Genetic Testing
  • List of US-FDA Approved Biomarkers for Cancer
  • Ballooning Global Population Offers Increased Growth Opportunities
  • Aging Population Drives the Genetic Testing Market
  • Improving Healthcare Expenditure to Drive Demand
  • Competitive Overview
  • Global Competitor Market Shares
  • Genetic Testing Competitor Market Share Scenario Worldwide (in %): 2020 & 2029

2. FOCUS ON SELECT PLAYERS

  • 23andMe, Inc. (USA)
  • Abbott Laboratories (USA)
  • AutoGenomics, Inc. (USA)
  • Biocartis NV (Belgium)
  • BioRad Laboratories (USA)
  • Cepheid Inc. (USA)
  • ELITech Group S.P.A. (France)
  • Illumina, Inc. (USA)
  • Laboratory Corporation of America Holdings (USA)
  • Sequenom, Inc. (USA)
  • Luminex Corporation (USA)
  • Natera, Inc. (USA)
  • PerkinElmer, Inc. (USA)
  • QIAGEN N.V. (The Netherlands)
  • PerkinElmer, Inc. (USA)
  • Roche Diagnostics AG (Switzerland)
  • Roche Molecular Diagnostics, Inc. (USA)
  • Thermo Fisher Scientific Inc. (USA)

3. MARKET TRENDS & DRIVERS

  • Direct-to-Consumer Genetic Testing - A Key Trend in the Genetic Testing Market
  • Direct-to-Consumer Genetic Testing is Here to Stay
  • Creating a Platform for New Companies
  • Business Models for DTC Genetic Testing Firms
  • Growing Prominence of DTC Genetic Testing: A Boon or a Curse?
  • Challenges to DTC-GT Market
  • Considerations for Market Entry
  • Emphasizing Consumer Empowerment
  • Offer Wraparound Provision
  • Offer Wraparound Provision
  • Whole Genome Sequencing (WGS) - Boon or Bane to Genetic Testing?
  • Utility of Genetic Testing for Warfarin Study
  • As Technologies Grow, Need for Better Interpretation of Tests Increases
  • Focus on Health & Wellness and Genetic Counseling
  • Selling Collected Patient Genetic Information Becomes a New Business
  • Oncology - A Key Focus Area for Genetic Testing
  • Liquid Biopsy to Change the Face of Cancer Diagnosis and Treatment
  • Genetic Testing May Aid CNS Disease Therapeutics
  • Neurodegenerative Diseases - Another Major Focus Area for Genetic Testing
  • Alzheimer's Disease
  • Validity of Emerging Genetic Tests for Alzheimer's
  • Newly Developed Test Predicts Age of Onset of Alzheimer's
  • Huntington's Disease
  • Genetic Testing - An Indispensable Tool for Cystic Fibrosis
  • Recommendations of ACOG and ACGM Augments Demand for Cystic Fibrosis Testing
  • Histocompatibility Testing
  • Pediatric Genetic Testing for Screening Adult Onset Disorders Fast Gaining Acceptance
  • Point-of-Care Genetic Testing Gains Popularity
  • Better Regulatory Safeguards Required for Global Genetic Testing Industry
  • Challenges Faced
  • Controversial Applications Marr Genetic Testing Market
  • Genetic Counseling Gaining Momentum
  • Online Approach Gains Momentum
  • Ethical Issues & Need for Appropriate Regulating Policies
  • Issues Related to Genetic Tests for Obesity
  • Diagnosis and Treatment during Pregnancy - An Effective Way of Alleviating Syphilis Related Deaths and Stillbirths

4. GLOBAL MARKET PERSPECTIVE

  • TABLE 1: Genetic Testing Global Market Estimates and Forecasts in US$ Million by Region/Country: 2018-2025
  • TABLE 2: Genetic Testing Global Retrospective Market Scenario in US$ Million by Region/Country: 2009-2017
  • TABLE 3: Genetic Testing Market Share Shift across Key Geographies Worldwide: 2009 VS 2019 VS 2025

III. MARKET ANALYSIS

  • GEOGRAPHIC MARKET ANALYSIS
  • UNITED STATES
    • Market Facts & Figures
    • Market Analytics
    • TABLE 4: United States Genetic Testing Market Estimates and Projections in US$ Million: 2018 to 2025
    • TABLE 5: Genetic Testing Market in the United States: A Historic Review in US$ Million for 2009-2017
  • CANADA
    • TABLE 6: Canadian Genetic Testing Market Estimates and Forecasts in US$ Million: 2018 to 2025
    • TABLE 7: Canadian Genetic Testing Historic Market Review in US$ Million: 2009-2017
  • JAPAN
    • TABLE 8: Japanese Market for Genetic Testing: Annual Sales Estimates and Projections in US$ Million for the Period 2018-2025
    • TABLE 9: Genetic Testing Market in Japan: Historic Sales Analysis in US$ Million for the Period 2009-2017
  • CHINA
    • TABLE 10: Chinese Genetic Testing Market Growth Prospects in US$ Million for the Period 2018-2025
    • TABLE 11: Genetic Testing Historic Market Analysis in China in US$ Million: 2009-2017
  • EUROPE
    • Market Facts & Figures
    • Market Analytics
    • TABLE 12: European Genetic Testing Market Demand Scenario in US$ Million by Region/Country: 2018-2025
    • TABLE 13: Genetic Testing Market in Europe: A Historic Market Perspective in US$ Million by Region/Country for the Period 2009-2017
    • TABLE 14: European Genetic Testing Market Share Shift by Region/Country: 2009 VS 2019 VS 2025
  • FRANCE
    • TABLE 15: Genetic Testing Market in France: Estimates and Projections in US$ Million for the Period 2018-2025
    • TABLE 16: French Genetic Testing Historic Market Scenario in US$ Million: 2009-2017
  • GERMANY
    • TABLE 17: Genetic Testing Market in Germany: Recent Past, Current and Future Analysis in US$ Million for the Period 2018-2025
    • TABLE 18: German Genetic Testing Historic Market Analysis in US$ Million: 2009-2017
  • ITALY
    • TABLE 19: Italian Genetic Testing Market Growth Prospects in US$ Million for the Period 2018-2025
    • TABLE 20: Genetic Testing Historic Market Analysis in Italy in US$ Million: 2009-2017
  • UNITED KINGDOM
    • TABLE 21: United Kingdom Market for Genetic Testing: Annual Sales Estimates and Projections in US$ Million for the Period 2018-2025
    • TABLE 22: Genetic Testing Market in the United Kingdom: Historic Sales Analysis in US$ Million for the Period 2009-2017
  • REST OF EUROPE
    • TABLE 23: Rest of Europe Genetic Testing Market Estimates and Forecasts in US$ Million: 2018-2025
    • TABLE 24: Genetic Testing Market in Rest of Europe in US$ Million: A Historic Review for the Period 2009-2017
  • ASIA-PACIFIC
    • TABLE 25: Genetic Testing Market in Asia-Pacific: Estimates and Projections in US$ Million for the Period 2018-2025
    • TABLE 26: Asia-Pacific Genetic Testing Historic Market Scenario in US$ Million: 2009-2017
  • REST OF WORLD
    • TABLE 27: Rest of World Genetic Testing Market Estimates and Forecasts in US$ Million: 2018 to 2025
    • TABLE 28: Rest of World Genetic Testing Historic Market Review in US$ Million: 2009-2017

IV. COMPETITION

  • Total Companies Profiled: 85
  • GENETIC TESTING MCP-1392
  • CONTENTS